Genting to develop first stem cell facility in Bali, expand into healthcare
Fontaine Vitale will be the first in Asean to offer placenta-derived allogeneic stem cell therapy
Add BT as a preferred source
[KUALA LUMPUR] Malaysian conglomerate Genting has launched its first stem cell facility in Bali, Indonesia, marking a significant milestone in its expansion into advanced healthcare and medical tourism.
The Fontaine Vitale facility, located in the Sanur Special Economic Zone (SEZ), will be operated by Genting’s 56-per-cent-owned indirect subsidiary Astana Bangun Sejahtera, in partnership with Indonesian companies Sentosa Bersama Mitra and Bintang Graha Hijau.
Fontaine Vitale will also collaborate with US-based Celularity to integrate cutting-edge expertise in cellular and regenerative medicine, bringing advanced therapies and treatments to the region.
TRENDING NOW
Qatari LNG ship struck in Strait of Hormuz, testing US talks
DBS, OCBC and UOB shares hit all-time highs as sentiment improves
‘Baptism of fire’: Andre Khor on leading Singapore refiner Aster through an energy crisis
Singapore retains top spot as most expensive city for HNWIs, with five Apac cities in global top 10
